A recent review published in the European Heart Journal explores the multifaceted aging process of the human heart, detailing both cellular and structural changes that occur over time. The review, authored by members of the International Consortium to Classify Ageing-Related Pathologies (ICCARP), highlights critical factors such as cellular senescence, mitochondrial dysfunction, and the resultant hypertrophy and fibrosis that contribute to increased heart failure rates in older adults.

Understanding these aging mechanisms is essential for developing effective therapies targeting age-related cardiovascular diseases. The review underscores the importance of distinguishing harmful changes from adaptive responses, such as hypertrophy, which can be protective. Additionally, it discusses promising therapeutic avenues like senolytics and senomorphics that may mitigate the effects of senescence and oxidative stress on cardiac function.

For professionals in the field, this comprehensive overview offers valuable insights into the complex interplay of heart aging and potential therapeutic strategies. I encourage you to read the full article for a deeper understanding of these critical developments in cardiac aging research.

Source: lifespan.io